DocGo Inc. (DCGO)
USD 4.29
(-2.39%)
USD 4.29
(-2.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12.78 Million USD | 90.69% |
| 2022 | -137.42 Million USD | 13.59% |
| 2021 | -159.02 Million USD | -758.35% |
| 2020 | -18.52 Million USD | 42.47% |
| 2019 | -32.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 10.95 Million USD | 185.68% |
| 2024 Q2 | -12.84 Million USD | -217.23% |
| 2023 Q1 | -99.63 Million USD | 27.5% |
| 2023 FY | -12.78 Million USD | 90.69% |
| 2023 Q4 | -12.78 Million USD | 59.73% |
| 2023 Q3 | -31.75 Million USD | 64.15% |
| 2023 Q2 | -88.59 Million USD | 11.07% |
| 2022 Q2 | -183.49 Million USD | -6.87% |
| 2022 Q1 | -171.7 Million USD | -7.97% |
| 2022 FY | -137.42 Million USD | 13.59% |
| 2022 Q4 | -137.42 Million USD | 7.79% |
| 2022 Q3 | -149.02 Million USD | 18.78% |
| 2021 Q1 | 10.01 Million USD | 154.04% |
| 2021 FY | -159.02 Million USD | -758.35% |
| 2021 Q3 | -16.14 Million USD | -53.08% |
| 2021 Q2 | -10.54 Million USD | -205.36% |
| 2021 Q4 | -159.02 Million USD | -884.8% |
| 2020 Q1 | 47.73 Million USD | 0.0% |
| 2020 Q4 | -18.52 Million USD | 0.0% |
| 2020 FY | -18.52 Million USD | 42.47% |
| 2019 FY | -32.2 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 100.907% |
| Addus HomeCare Corporation | 110.39 Million USD | 111.585% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 114.304% |
| Amedisys, Inc. | 341.35 Million USD | 103.747% |
| American Oncology Network, Inc. | 99.78 Million USD | 112.816% |
| Astrana Health, Inc. | 27.2 Million USD | 147.006% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 100.879% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | -5673.53% |
| biote Corp. | 25.86 Million USD | 149.438% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 221.917% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | -8.134% |
| COMPASS Pathways plc | -187.58 Million USD | 93.182% |
| The Ensign Group, Inc. | 1.36 Billion USD | 100.939% |
| Healthcare Services Group, Inc. | -10.69 Million USD | -19.579% |
| InnovAge Holding Corp. | 56.08 Million USD | 122.801% |
| Assure Holdings Corp. | 14.68 Million USD | 187.107% |
| The Joint Corp. | -2.47 Million USD | -415.798% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 102.959% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | -111.369% |
| ModivCare Inc. | 1.13 Billion USD | 101.125% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 4692.943% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | 415.363% |
| Option Care Health, Inc. | 822.56 Million USD | 101.555% |
| P3 Health Partners Inc. | 83.7 Million USD | 115.278% |
| P3 Health Partners Inc. | 83.7 Million USD | 115.278% |
| The Pennant Group, Inc. | 323.57 Million USD | 103.952% |
| Surgery Partners, Inc. | 2.86 Billion USD | 100.446% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | -321.805% |
| Talkspace, Inc. | -123.9 Million USD | 89.679% |
| Talkspace, Inc. | -123.9 Million USD | 89.679% |
| The Oncology Institute, Inc. | 86.32 Million USD | 114.815% |
| The Oncology Institute, Inc. | 86.32 Million USD | 114.815% |